Patents
Patents for A61K 38 - Medicinal preparations containing peptides (316,240)
09/1991
09/24/1991US5051496 Polypeptides encoded by DNA fragments for detection of AIDS
09/24/1991US5051443 Wound healing agents for eyes a nonsteroid antiinflammatory agent
09/24/1991US5051405 Modified dipeptides and tripeptides as anticoagulants
09/24/1991US5051404 Tripeptide compounds having hypotensive activity
09/24/1991US5051403 Method of treating ischemia-related neuronal damage
09/24/1991US5051402 Fungicides, immunosuppressants and antiphlogistic agents
09/24/1991US5051401 Inhibition of mineral deposition by phosphorylated and related polyanionic peptides
09/24/1991US5051400 Administering oligopeptides as antiemetics
09/24/1991US5051371 Polypeptides with cystine groups for diagnosis of cancer and the immune systems
09/24/1991US5051363 Method for modifying the toxicity of DNA reactive cross-linking agents to cells
09/24/1991US5051353 Preservation and restoration of hemoglobin in blood substitutes
09/24/1991US5051264 Controlling the fibrinolytic system for treatment of myocardial infraction
09/24/1991CA2037151A1 Plasmodium sporozoite antigen
09/24/1991CA1289472C Tpa-containing medical composition
09/24/1991CA1289420C Method of producing high aqueous volume multilamellar vesicles
09/23/1991WO1991014447A1 MOLECULAR CLONING OF THE GENES RESPONSIBLE FOR COLLAGENASE PRODUCTION FROM $i(CLOSTRIDIUM HISTOLYTICUM)
09/23/1991CA2078783A1 Molecular cloning of the genes responsible for collagenase production from clostridium histolyticum
09/23/1991CA2038509A1 Bu-4164e - a and b, prolyl endopeptidase inhibitors
09/22/1991WO1991014436A1 Reagents and methods for modulating gene expression through rna mimicry
09/22/1991CA2078659A1 Reagents and methods for modulating gene expression through rna mimicry
09/21/1991CA2038581A1 Seroreactive epitopes of human papillomavirus (hpv) 16 proteins
09/21/1991CA2038534A1 Hyperimmune globulin against hepatitis c virus and method for making same
09/20/1991CA2038547A1 Lipopeptide compounds
09/20/1991CA2038532A1 Antibiotic agents
09/20/1991CA2038528A1 Lipopeptide derivatives
09/20/1991CA2038525A1 Lipopeptide compounds
09/20/1991CA2038497A1 Lipopeptide derivatives
09/20/1991CA2038495A1 Antibiotic agents
09/20/1991CA2038397A1 Monoclonal antibody reactive with a novel hla determinant on mhc class i molecules and method for activating lymphocytes
09/19/1991WO1991013986A1 PORCINE INTERLEUKIN-1α NUCLEOTIDE SEQUENCES AND POLYPEPTIDES
09/19/1991WO1991013985A1 Leukaemia inhibitory factor
09/19/1991WO1991013982A1 Genetically engineered human lactoferrin
09/19/1991WO1991013981A1 New protein, its manufacture and use
09/19/1991WO1991013911A1 Peptide inhibitor of human immunodeficiency virus infection blocks virus interactions with a novel cellular receptor
09/19/1991WO1991013908A1 Neutrophil stimulating peptides
09/19/1991WO1991013905A1 Virus free platelet derivatives and method of making same
09/19/1991WO1991013631A1 Method for enhancing antibody transport through capillary barriers
09/19/1991WO1991013629A1 Use of lactoferrin to counter the toxic effects of endotoxins
09/19/1991WO1991013628A1 Pharmaceutical compositions
09/19/1991WO1991012270A3 Novel platelet aggregation inhibitors from the leech
09/19/1991WO1991011515A3 Leukocyte-derived growth factor
09/19/1991WO1991011117A3 Dietary supplements comprising vitamins and minerals
09/19/1991WO1991004058A3 Treatment of conditions and disease
09/19/1991DE4008354A1 Neues protein, seine herstellung und verwendung Novel protein, its preparation and use
09/18/1991EP0447353A1 A pharmaceutical preparation for the maturation of prothymocytes
09/18/1991EP0447298A1 Method for coating active agents with PH-sensitive polymers
09/18/1991EP0447188A2 7-Oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic diseases
09/18/1991EP0447186A1 N-acylated cyclohexapeptide compounds
09/18/1991EP0446931A1 Human ciliary neuronotrophic factor, DNA sequence encoding the factor, and production of the factor by recombinant technology
09/18/1991EP0446876A2 Secretory component-containing composition
09/18/1991EP0446850A2 Process for purifying recombinant human beta-interferon
09/18/1991EP0446797A2 Synthetic peptides containing factor VIIa sequences and their use
09/18/1991EP0446763A2 Antigen for producing anti-idiotype antibody, anti-idiotype antibody and method for producing the anti-idiotype antibody
09/18/1991EP0446706A2 Peptides with tachykinin-agonistic or -antagonistic activity
09/18/1991EP0446699A1 Inhibitors of nitric oxide biosynthesis
09/18/1991EP0446582A1 Method for producing of recombinant human cysteineless gamma-interferon free of methionine at n-terminal
09/18/1991EP0446485A2 Peptide analogues with renininhibiting activity
09/18/1991EP0446361A1 Polypeptide, production thereof, and pharmaceutical composition and cosmetic containing said polypeptide
09/18/1991EP0446298A1 Fast buccal tablet
09/18/1991EP0446283A1 Synthetic interleukin-6
09/18/1991EP0446279A1 Treatment of squamous cell carcinoma intralesionally with recombinant human alpha interferon
09/18/1991EP0446230A1 Treatment of myelosuppression associated with acquired immune deficiency
09/18/1991EP0193608B1 Gif-2 and its preparation
09/18/1991EP0126153B1 Vascular permeability factor
09/18/1991CN1054537A Improved diluent formulation for daptomycin
09/17/1991US5049659 Proteins which induce immunological effector cell activation and chemattraction
09/17/1991US5049658 Polypeptide with cell-spreading activity
09/17/1991US5049655 Melanin-concentrating hormones
09/17/1991US5049654 Calcitonin gene related peptide derivatives
09/17/1991US5049553 Angiotensin converting enzyme inhibitor
09/17/1991US5049552 Compositions containing hexadecylphosphocholine and use thereof
09/17/1991US5049548 Hypotensives
09/17/1991US5049547 Polypeptide hormone for tanning
09/17/1991US5049546 Fungicides
09/17/1991US5049545 Insulin derivatives, a process for their preparation, and their use
09/17/1991US5049392 Osmotically dependent vesicles
09/17/1991US5049391 Liposome encapsulated hemoglobin
09/17/1991US5049378 Prevention and treatment of porcine haemophilus pneumonia (PHP)
09/17/1991CA1289092C Thermostable human cu/zn superoxide dismutase muteins
09/17/1991CA1289072C Scaled-up production of liposome-encapsulated hemoglobin
09/17/1991CA1289071C Pharmaceutical compositions for parenteral use containing a calcitonin as the active ingredient
09/16/1991WO1991013909A1 Synthetic polypeptides
09/16/1991WO1991013601A1 Calcitonin suppository formulations
09/16/1991CA2078220A1 Synthetic polypeptides
09/16/1991CA2078133A1 Calcitonin suppository formulations
09/15/1991CA2038208A1 Process for the isolation and expression of the human ciliary neuronotrophic factor by recombinant dna technology
09/14/1991CA2037990A1 Amino acid derivatives
09/13/1991CA2037957A1 N-acylated cyclohexapeptide compounds
09/13/1991CA2037821A1 Amyloid peptide precursor rna
09/13/1991CA2036486A1 7-oxabicycloheptane imidazole prostaglandin analogs useful in the treatment of thrombotic and vasospastic disease
09/11/1991EP0446071A2 Tris-maleimido compounds as intermediates in trifunctional antibody synthesis
09/11/1991EP0446017A1 New diagnostic and treatment methods involving the cystic fibrosis transmembrane regulator
09/11/1991EP0445971A1 DNA encoding a major mite allergen and the use thereof
09/11/1991EP0445894A2 Use of tumor necrosis factor
09/11/1991EP0445796A2 Derivatives of acetic acid
09/11/1991EP0445681A2 Preparation of a thrombin-binding substance
09/11/1991EP0445625A1 Human monoclonal antibody against rabies virus, its production and use
09/11/1991EP0445606A1 Novel oligopeptides, pharmaceutical composition and food containing the same, and use of oligopeptides
09/11/1991EP0445581A1 Stable immunostimulating preparation for parenteral application, preparation and use thereof
09/11/1991EP0445467A1 Renin inhibitors and antiviral agents